Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INCRETIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 225 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ding, WG; Kitasato, H; Matsuura, H
      Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K+ channel in mouse pancreatic beta-cells

      EXPERIMENTAL PHYSIOLOGY
    2. Gutniak, MK; Svartberg, J; Hellstrom, PM; Holst, JJ; Adner, N; Ahren, B
      Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes

      JOURNAL OF INTERNAL MEDICINE
    3. Creutzfeldt, W
      The entero-insular axis in type 2 diabetes - incretins as therapeutic agents

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    4. Wettergren, A
      Glucagon-like peptide-1 - Gastrointestinal function and possible mechanismof action

      DANISH MEDICAL BULLETIN
    5. Vilsboll, T; Krarup, T; Madsbad, S; Holst, JJ
      No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose

      DIABETIC MEDICINE
    6. Bollag, RJ; Zhong, Q; Ding, KH; Phillips, P; Zhong, L; Qin, F; Cranford, J; Mulloy, AL; Cameron, R; Isales, CM
      Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    7. Fery, F; Deviere, J; Balasse, EO
      Metabolic handling of intraduodenal vs. intravenous glucose in humans

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    8. Nakagawa, A; Azuma, S; Nakabayashi, H
      Novel gastroinsular axis involving a gastric transmural glucose flux and vagal mediation

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    9. Edwards, CMB; Stanley, SA; Davis, R; Brynes, AE; Frost, GS; Seal, LJ; Ghatei, MA; Bloom, SR
      Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    10. Tolessa, T; Naslund, E; Hellstrom, PM
      The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the L-arginine/nitric oxide pathway

      REGULATORY PEPTIDES
    11. Gebhard, B; Holst, JJ; Biegelmayer, C; Miholic, J
      Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome

      DIGESTIVE DISEASES AND SCIENCES
    12. Larsen, J; Hylleberg, B; Ng, K; Damsbo, P
      Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtainacceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment

      DIABETES CARE
    13. Holst, JJ; Orskov, C
      Incretin hormones - an update

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    14. Toft-Nielsen, MB; Madsbad, S; Holst, JJ
      Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    15. Garcia-Flores, M; Zueco, JA; Alvarez, E; Blazquez, E
      Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    16. Reimer, RA; Darimont, C; Gremlich, S; Nicolas-Metral, V; Ruegg, UT; Mace, K
      A human cellular model for studying the regulation of glucagon-like peptide-1 secretion

      ENDOCRINOLOGY
    17. Ritzel, R; Schulte, M; Porksen, N; Nauck, MS; Holst, JJ; Juhl, C; Marz, W; Schmitz, O; Schmiegel, WH; Nauck, MA
      Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance

      DIABETES
    18. Vella, A; Shah, P; Basu, R; Basu, A; Camilleri, M; Schwenk, FW; Holst, JJ; Rizza, RA
      Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes

      DIABETES
    19. Vilsboll, T; Krarup, T; Deacon, CF; Madsbad, S; Holst, JJ
      Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients

      DIABETES
    20. Meier, JJ; Huking, K; Holst, JJ; Deacon, CF; Schmiegel, WH; Nauck, MA
      Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

      DIABETES
    21. Neidigh, JW; Fesinmeyer, RM; Prickett, KS; Andersen, NH
      Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states

      BIOCHEMISTRY
    22. Gin, H; Rigalleau, V
      Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes

      DIABETES & METABOLISM
    23. D'Alessio, D
      Glucagon-like peptide 1 (GLP-1) in diabetes and aging

      JOURNAL OF ANTI-AGING MEDICINE
    24. Nauck, M; Hahn, S; Sauerwald, A; Schmiegel, W
      Lack of germline mutations in the preproglucagon gene region coding for glucagon-like peptide 1 in Type 2 diabetic (NIDDM) patients

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    25. Hedetoft, C; Sheikh, SP; Larsen, S; Holst, JJ
      Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis

      PANCREAS
    26. Perfetti, R; Merkel, P
      Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    27. Balkan, B; Li, X
      Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    28. Beuschlein, F; Borgemeister, M; Schirra, J; Goke, B; Fassnacht, M; Arlt, W; Allolio, B; Reincke, M
      Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas

      CLINICAL ENDOCRINOLOGY
    29. Persson, K; Gingerich, RL; Nayak, S; Wada, K; Wada, E; Ahren, B
      Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    30. Ebinger, M; Jehle, DR; Fussgaenger, RD; Fehmann, HC; Jehle, PM
      Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    31. Gallwitz, B; Ropeter, T; Morys-Wortmann, C; Mentlein, R; Siegel, EG; Schmidt, WE
      GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro

      REGULATORY PEPTIDES
    32. Nishizawa, M; Nakabayashi, H; Kawai, K; Ito, T; Kawakami, S; Nakagawa, A; Niijima, A; Uchida, K
      The hepatic vagal reception of intraportal GLP-1 is via receptor differentfrom the pancreatic GLP-1 receptor

      JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM
    33. Ohnuma, H; Yamatani, K; Daimon, M; Igarashi, M; Manaka, H; Sasaki, H; Kato, T
      Impaired neural regulation of insulin secretion related to the leptin receptor gene mutation in Wistar fatty rats

      PHYSIOLOGY & BEHAVIOR
    34. Heptulla, RA; Tamborlane, WV; Cavaghan, M; Bronson, M; Limb, C; Ma, YZ; Sherwin, RS; Caprio, S
      Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity

      PEDIATRIC RESEARCH
    35. Knudsen, LB; Nielsen, PF; Huusfeldt, PO; Johansen, NL; Madsen, K; Pedersen, FZ; Thogersen, H; Wilken, M; Agerso, H
      Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration

      JOURNAL OF MEDICINAL CHEMISTRY
    36. O'Harte, FPM; Mooney, MH; Kelly, CMN; Flatt, PR
      Improved glycaemic control in obese diabetic ob/ob mice using N-terminallymodified gastric inhibitory polypeptide

      JOURNAL OF ENDOCRINOLOGY
    37. Deacon, CF; Nauck, MA; Meier, J; Hucking, K; Holst, JJ
      Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    38. Lugari, R; Dell'Anna, C; Ugolotti, D; Dei Cas, A; Barilli, AL; Zandomeneghi, R; Marani, B; Lotti, M; Orlandini, A; Gnudi, A
      Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes

      HORMONE AND METABOLIC RESEARCH
    39. Schirra, J; Houck, P; Wank, U; Arnold, R; Goke, B; Katschinski, M
      Effects of glucagon-like peptide-1 (7-36) amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

      GUT
    40. Fritsche, A; Stefan, N; Hardt, E; Schutzenauer, S; Haring, H; Stumvoll, M
      A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    41. Satoh, F; Beak, SA; Small, CJ; Falzon, M; Ghatei, MA; Bloom, SR; Smith, DM
      Characterization of human and rat glucagon-like peptide-1 receptors in theneurointermediate lobe: Lack of coupling to either stimulation or inhibition of adenylyl cyclase

      ENDOCRINOLOGY
    42. Bollag, RJ; Zhong, Q; Phillips, P; Min, L; Zhong, L; Cameron, R; Mulloy, AL; Rasmussen, H; Qin, F; Ding, KH; Isales, CM
      Osteoblast-derived cells express functional glucose dependent insulinotropic peptide receptors

      ENDOCRINOLOGY
    43. Seeley, RJ; Woods, SC; D'Alessio, D
      Editorial: Targeted gene disruption in endocrine research - The case of glucagon-like peptide-1 and neuroendocrine function

      ENDOCRINOLOGY
    44. Lewis, JT; Dayanandan, B; Habener, JF; Kieffer, TJ
      Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: Demonstration by a receptor antagonist

      ENDOCRINOLOGY
    45. Peracchi, M; Santangelo, A; Conte, D; Fraquelli, M; Tagliabue, R; Gebbia, C; Porrini, M
      The physical state of a meal affects hormone release and postprandial thermogenesis

      BRITISH JOURNAL OF NUTRITION
    46. Mojsov, S
      Glucagon-like peptide-1 (GLP-1) and the control of glucose metabolism in mammals and teleost fish

      AMERICAN ZOOLOGIST
    47. Brynes, AE; Edwards, CM; Jadhav, A; Ghatei, MA; Bloom, SR; Frost, GS
      Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    48. Ranganath, L; Schaper, F; Gama, R; Morgan, L; Wright, J; Teale, D; Marks, V
      Effect of glucagon on carbohydrate-mediated secretion of glucose-dependentinsulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1)

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    49. Holst, JJ
      Glucagon-like peptide 1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    50. van der Burg, MPM; van Suylichem, PTR; Guicherit, OR; Frolich, M; Lemkes, HHPJ; Gooszen, HG
      The relative contribution of insulin secretory capacity, insulin action, and incretins to metabolic control after islet transplantation in dogs

      JOURNAL OF MOLECULAR MEDICINE-JMM
    51. Holst, JJ
      Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential

      CURRENT MEDICINAL CHEMISTRY
    52. Naslund, E; Bogefors, J; Skogar, S; Gryback, P; Jacobsson, H; Holst, JJ; Hellstrom, PM
      GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYYrelease in humans

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    53. Carlsson, PO; Iwase, M; Jansson, L
      Stimulation of intestinal glucoreceptors in rats increases pancreatic islet blood flow through vagal mechanisms

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    54. Tseng, CC; Zhang, XY; Wolfe, MM
      Effect of GIP and GLP-1 antagonists on insulin release in the rat

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    55. Ahren, B; Pacini, G
      Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    56. Brundin, T
      Splanchnic and extrasplanchnic extraction of insulin following oral and intravenous glucose loads

      CLINICAL SCIENCE
    57. Livingston, JN; Schoen, WR
      Glucagon and glucagon-like peptide-1

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34
    58. Chang, FY; Chen, TS; Lee, SD; Doong, ML; Wang, PS
      Misoprostol-inhibited rat gastric emptying is independent of gastric inhibitory polypeptide release

      PHARMACOLOGY
    59. Meurer, JA; Colca, JR; Burton, PS; Elhammer, AP
      Properties of native and in vitro glycosylated forms of the glucagon-like peptide-1 receptor antagonist exendin(9-39)

      METABOLISM-CLINICAL AND EXPERIMENTAL
    60. Kissler, HJ; Gepp, H; Schmiedl, A; Schwille, PO
      Preservation of the incretin effect after orthotopic pancreas transplantation in inbred rats

      METABOLISM-CLINICAL AND EXPERIMENTAL
    61. Freyse, EJ; Knospe, S; Becher, T; El Hag, O; Goke, B; Fischer, U
      Glucagon-like peptide-1 has no insulin-like effects in insulin-dependent diabetic dogs maintained normoglycemic and normoinsulinemic

      METABOLISM-CLINICAL AND EXPERIMENTAL
    62. Faulkner, A; Martin, PA
      Insulin secretion and intestinal peptides during lactation in sheep

      JOURNAL OF DAIRY RESEARCH
    63. Edwards, CMB; Bloom, SR
      The incretins - outdated terminology in man?

      DIABETOLOGIA
    64. Nauck, MA
      Is glucagon-like peptide 1 an incretin hormone?

      DIABETOLOGIA
    65. Nyholm, B; Walker, M; Gravholt, CH; Shearing, PA; Sturis, J; Alberti, KGMM; Holst, JJ; Schmitz, O
      Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations

      DIABETOLOGIA
    66. Balkan, B; Kwasnik, L; Miserendino, R; Holst, JJ; Li, X
      Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obeseZucker rats

      DIABETOLOGIA
    67. Edwards, CMB; Todd, JF; Mahmoudi, M; Wang, ZL; Wang, RM; Ghatei, MA; Bloom, SR
      Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans - Studies with the antagonist exendin 9-39

      DIABETES
    68. Hiroyoshi, M; Tateishi, K; Yasunami, Y; Maeshiro, K; Ono, J; Matsuoka, Y; Ikeda, S
      Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    69. Tammen, H; Forssmann, WG; Richter, R
      Proteolytic cleavage of glucagon-like peptide-1 by pancreatic beta cells and by fetal calf serum analyzed by mass spectrometry

      JOURNAL OF CHROMATOGRAPHY A
    70. SIEGEL EG; GALLWITZ B; FOLSCH UR; SCHMIDT WE
      EFFECT OF HUMAN PANCREASTATIN PEPTIDE (HP-16) ON ORAL GLUCOSE-TOLERANCE IN MAN

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    71. WILLMS B; IDOWU K; HOLST JJ; CREUTZFELDT W; NAUCK MA
      OVERNIGHT GLP-1 NORMALIZES FASTING BUT NOT DAYTIME PLASMA-GLUCOSE LEVELS IN NIDDM PATIENTS

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    72. NAUCK MA
      GLUCAGON-LIKE-PEPTIDE-1 (GLP-1) - A POTENT GUT HORMONE WITH A POSSIBLE THERAPEUTIC PERSPECTIVE

      Acta diabetologica
    73. KIMURA I; SASAMURA T; TSUNEKI H; IWAI M; FURUTA I; SASAMOTO H; FURUSAWA Y
      IMMUNOCYTOCHEMICAL LOCALIZATION OF SALIVARY PEPTIDE P-C IN HUMAN SUBMANDIBULAR-GLAND

      Biological & pharmaceutical bulletin
    74. BRYNES AE; FROST GS; EDWARDS MB; GHATEL MA; BLOOM SR
      PLASMA GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE (GLP-1) RESPONSE TO LIQUID-PHASE, SOLID-PHASE, AND MEALS OF DIFFERING LIPID-COMPOSITION

      Nutrition
    75. FEHMANN HC; PRACHT A; GOKE B
      HIGH-LEVEL EXPRESSION OF THE GLP-I RECEPTOR RESULTS IN RECEPTOR DESENSITIZATION

      Pancreas
    76. NAITO H; SASAKI I; MATSUNO S
      SURGICAL ASPECT OF ENTEROINSULAR AXIS AFTER GASTROINTESTINAL SURGERY WITH REFERENCE TO INCRETIN SECRETION

      Pancreas
    77. SVARTBERG J; HOLST JJ; GUTNIAK M; ADNER N
      THE ETHANOL AUGMENTATION OF GLUCOSE-INDUCED INSULIN-SECRETION IS ABOLISHED BY CALCIUM ANTAGONISM WITH NIFEDIPINE - NO EVIDENCE FOR A ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)

      Pancreas
    78. SEIFARTH C; BERGMANN J; HOLST JJ; RITZEL R; SCHMIEGEL W; NAUCK MA
      PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS

      Diabetic medicine
    79. NAUCK MA; WEBER I; BACH I; RICHTER S; ORSKOV C; HOLST JJ; SCHMIEGEL W
      NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS

      Diabetic medicine
    80. SHALEV A; NINNIS R; KELLER U
      EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) ON GLUCOSE KINETICS DURING SOMATOSTATIN-INDUCED SUPPRESSION OF INSULIN-SECRETION IN HEALTHY-MEN

      Hormone research
    81. MORGAN LM
      THE ROLE OF GASTROINTESTINAL HORMONES IN CARBOHYDRATE AND LIPID-METABOLISM AND HOMEOSTASIS - EFFECTS OF GASTRIC-INHIBITORY POLYPEPTIDE AND GLUCAGON-LIKE PEPTIDE-I

      Biochemical Society transactions
    82. WISHART JM; HOROWITZ M; MORRIS HA; JONES KL; NAUCK MA
      RELATION BETWEEN GASTRIC-EMPTYING OF GLUCOSE AND PLASMA-CONCENTRATIONS OF GLUCAGON-LIKE PEPTIDE-1

      Peptides (New York, N.Y. 1980)
    83. WETTERGREN A; PRIDAL L; WOJDEMANN M; HOLST JJ
      AMIDATED AND NON-AMIDATED GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - NONPANCREATIC EFFECTS (CEPHALIC PHASE ACID-SECRETION) AND STABILITY IN PLASMA IN HUMANS

      Regulatory peptides
    84. TODD JF; EDWARDS CMB; GHATEI MA; MATHER HM; BLOOM SR
      SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-I IMPROVES POSTPRANDIAL GLYCEMIC CONTROL OVER A 3-WEEK PERIOD IN PATIENTS WITH EARLY-TYPE-2 DIABETES

      Clinical science
    85. Edwards, CMB; Todd, JF; Ghatei, MA; Bloom, SR
      Subcutaneous glucagon-like peptide-I (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects

      CLINICAL SCIENCE
    86. SCHIRRA J; LEICHT P; HILDEBRAND P; BEGLINGER C; ARNOLD R; GOKE B; KATSCHINSKI M
      MECHANISMS OF THE ANTIDIABETIC ACTION OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Journal of Endocrinology
    87. SCHIRRA J; STURM K; LEICHT P; ARNOLD R; GOKE B; KATSCHINSKI M
      EXENDIN(9-39)AMIDE IS AN ANTAGONIST OF GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE IN HUMANS

      The Journal of clinical investigation
    88. FLINT A; RABEN A; ASTRUP A; HOLST JJ
      GLUCAGON-LIKE PEPTIDE-1 PROMOTES SATIETY AND SUPPRESSES ENERGY-INTAKEIN HUMANS

      The Journal of clinical investigation
    89. SCROCCHI LA; DRUCKER DJ
      EFFECTS OF AGING AND A HIGH-FAT DIET ON BODY-WEIGHT AND GLUCOSE-TOLERANCE IN GLUCAGON-LIKE PEPTIDE-1 RECEPTOR(- -) MICE/

      Endocrinology
    90. SERRE V; DOLCI W; SCHAERER E; SCROCCHI L; DRUCKER D; EFRAT S; THORENS B
      EXENDIN-(9-39) IS AN INVERSE AGONIST OF THE MURINE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR - IMPLICATIONS FOR BASAL INTRACELLULAR CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE LEVELS AND BETA-CELL GLUCOSE COMPETENCE

      Endocrinology
    91. BRUBAKER PL; SCHLOOS J; DRUCKER DJ
      REGULATION OF GLUCAGON-LIKE PEPTIDE-1 SYNTHESIS AND SECRETION IN THE GLUTAG ENTEROENDOCRINE CELL-LINE

      Endocrinology
    92. TOFTNIELSEN M; MADSBAD S; HOLST JJ
      EXAGGERATED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) COULD CAUSE REACTIVE HYPOGLYCEMIA

      Diabetologia
    93. CORDIERBUSSAT M; BERNARD C; LEVENEZ F; KLAGES N; LASERRITZ B; PHILIPPE J; CHAYVIALLE JA; CUBER JC
      PEPTONES STIMULATE BOTH THE SECRETION OF THE INCRETIN HORMONE GLUCAGON-LIKE PEPTIDE-1 AND THE TRANSCRIPTION OF THE PROGLUCAGON GENE

      Diabetes
    94. SCROCCHI LA; MARSHALL BA; COOK SM; BRUBAKER PL; DRUCKER DJ
      IDENTIFICATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ACTIONS ESSENTIAL FOR GLUCOSE-HOMEOSTASIS IN MICE WITH DISRUPTION OF GLP-1 RECEPTOR SIGNALING

      Diabetes
    95. HOLST JJ; DEACON CF
      INHIBITION OF THE ACTIVITY OF DIPEPTIDYL-PEPTIDASE-IV AS A TREATMENT FOR TYPE-2 DIABETES

      Diabetes
    96. LAVIN JH; WITTERT GA; ANDREWS J; YEAP B; WISHART JM; MORRIS HA; MORLEY JE; HOROWITZ M; READ NW
      INTERACTION OF INSULIN, GLUCAGON-LIKE PEPTIDE-1, GASTRIC-INHIBITORY POLYPEPTIDE, AND APPETITE IN RESPONSE TO INTRADUODENAL CARBOHYDRATE

      The American journal of clinical nutrition
    97. SCHIRRA J; KUWERT P; WANK U; LEICHT P; ARNOLD R; GOKE B; KATSCHINSKI M
      DIFFERENTIAL-EFFECTS OF SUBCUTANEOUS GLP-1 ON GASTRIC-EMPTYING, ANTRODUODENAL MOTILITY, AND PANCREATIC FUNCTION IN MEN

      Proceedings of the Association of American Physicians
    98. DEORE K; GREIG NH; HOLLOWAY HW; WANG YH; PERFETTI R; EGAN JM
      THE EFFECTS OF GLP-1 ON INSULIN RELEASE IN YOUNG AND OLD RATS IN THE FASTING STATE AND DURING AN INTRAVENOUS GLUCOSE-TOLERANCE TEST

      The journals of gerontology. Series A, Biological sciences and medical sciences
    99. EDWARDS CMB; EDWARDS AV; BLOOM SR
      CARDIOVASCULAR AND PANCREATIC ENDOCRINE RESPONSES TO GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE IN THE CONSCIOUS CALF

      Experimental physiology
    100. WANG Y; KOLE HK; MONTROSERAFIZADEH C; PERFETTI R; BERNIER M; EGAN JM
      REGULATION OF GLUCOSE TRANSPORTERS AND HEXOSE UPTAKE IN 3T3-L1 ADIPOCYTES - GLUCAGON-LIKE PEPTIDE-1 AND INSULIN INTERACTIONS

      Journal of molecular endocrinology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/01/21 alle ore 23:25:41